CA2247329C - Compositions contenant un agent antitumoral - Google Patents

Compositions contenant un agent antitumoral Download PDF

Info

Publication number
CA2247329C
CA2247329C CA002247329A CA2247329A CA2247329C CA 2247329 C CA2247329 C CA 2247329C CA 002247329 A CA002247329 A CA 002247329A CA 2247329 A CA2247329 A CA 2247329A CA 2247329 C CA2247329 C CA 2247329C
Authority
CA
Canada
Prior art keywords
composition
indol
chloro
sulfamoylbenzenesulfonamide
basic substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002247329A
Other languages
English (en)
Other versions
CA2247329A1 (fr
Inventor
Kazuhide Ashizawa
Hidenobu Ando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority claimed from PCT/JP1997/000560 external-priority patent/WO1997030706A1/fr
Publication of CA2247329A1 publication Critical patent/CA2247329A1/fr
Application granted granted Critical
Publication of CA2247329C publication Critical patent/CA2247329C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

L'invention a trait à une solution à administration parentérale comportant un agent antitumoral peu soluble dans l'eau, une composition, en l'occurrence, contenant N-(3-chloro-1H-indol-7-yl)-4-sulfamoylbenzènesulfonamide ainsi qu'une substance de base et dont le pH en solution est égal ou supérieur à 7.
CA002247329A 1996-02-26 1997-02-26 Compositions contenant un agent antitumoral Expired - Fee Related CA2247329C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3776596 1996-02-26
JP8-37765 1996-02-26
PCT/JP1997/000560 WO1997030706A1 (fr) 1996-02-26 1997-02-26 Compositions contenant un agent antitumoral

Publications (2)

Publication Number Publication Date
CA2247329A1 CA2247329A1 (fr) 1997-08-28
CA2247329C true CA2247329C (fr) 2006-07-04

Family

ID=36648525

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002247329A Expired - Fee Related CA2247329C (fr) 1996-02-26 1997-02-26 Compositions contenant un agent antitumoral

Country Status (1)

Country Link
CA (1) CA2247329C (fr)

Also Published As

Publication number Publication date
CA2247329A1 (fr) 1997-08-28

Similar Documents

Publication Publication Date Title
US5756546A (en) Water-soluble nimesulide salt and its preparation, aqueous dolution containing it, nimesulide-based combinations and their uses
JP2568401B2 (ja) 水溶性メグルミン塩及びグルカミン塩、その製造方法並びにこれを含有する医薬組成物
ES2568475T3 (es) Cristales de derivado de morfinano y procedimiento para producir los mismos
EP0545194B1 (fr) Composition stabile contenant un sel d'énalapril, procédé pour la préparer et son utilisation
NO323815B1 (no) Karbapenemantibiotikum,farmasoytisk preparat omfattende dette og fremgangsmate for stabilisering av karbapenemantibiotikum.
NZ200908A (en) Salts of quinoline(and 1,8-naphthyridine)-3-carboxylic acids and antimicrobial compositions
AU775633B2 (en) Use of cell membrane penetrating indigoid bisindole derivatives
KR20010042603A (ko) 시알산 유도체를 함유하는 고체분산체
AU599034B2 (en) Furosemide salts
KR100760448B1 (ko) 벤즈아미딘 유도체 함유 조성물 및 벤즈아미딘 유도체의안정화 방법
KR100351952B1 (ko) 캠프토테신,그제조방법및항종양제
US6060498A (en) Composition containing antitumor agent
CA2247329C (fr) Compositions contenant un agent antitumoral
US4698361A (en) Tris-chydroxymethyl) aminomethane salt of 4-chloro-N-furfuryl-5-sulfamoyl anthranilic acid and diuretic compositions containing the same
US5183882A (en) 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions
EP0944612B1 (fr) Hydrate de n-(4-acetyl-1-piperazinyl)-4-fluorobenzamide
US6784315B2 (en) Stilbene derivative crystal and method for producing the same
SK283188B6 (sk) Spôsob prípravy kryštalickej formy 3/2 hydrátu 7-[(7-(S)- amino-5-azaspiro[2.4]-heptan-5-yl]-8-chlór-6-flór-1-[(1R,2S)-2- flórcyklopropyl]-4-oxo-1,4-dihydrochinolín-3-karboxylovej kyseliny
KR20150042275A (ko) 3-포르밀리파마이신 sv 및 3-포르밀리파마이신 s의 3-(4-신나밀-l-피페라지닐) 아미노 유도체를 함유하는 제약 제제 및 그의 제조 방법
JP3406334B2 (ja) チロシン特異的リン酸化酵素阻害剤及び制癌剤
JPH0699364B2 (ja) ズルシート類、その製造方法および該化合物の製造方法
KR920006420B1 (ko) 광학활성이 있는 류코보린칼슘염의 제조방법
KR100344099B1 (ko) 신규한비페닐디카르복실산유도체와이의제조방법
US4649199A (en) Salt of DC-52 and a pharmaceutical composition containing the same
US3461161A (en) Water-soluble tetracycline derivatives

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130226